ArticleFrontiers in microbiology2017
Antibacterial Activity of Silver Nanoparticles against
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 77 citations in OpenAlex.
- Eco-friendly synthesis of silver nanoparticles: multifaceted antioxidant, antidiabetic, anticancer, and antimicrobial activities.Scientific reports · 2025Article
- Assessing hydrocarbon degradation capacity ofFrontiers in microbiology · 2025Article
- Exploring the Antimicrobial, Antioxidant, and Antiviral Potential of Eco-Friendly Synthesized Silver Nanoparticles Using Leaf Aqueous Extract ofPharmaceuticals (Basel, Switzerland) · 2024Article
- The potential biological activities ofFrontiers in microbiology · 2024Article
- Unlocking the Potential of Nano-Enabled Precision Agriculture for Efficient and Sustainable Farming.Plants (Basel, Switzerland) · 2023Review
- Biosynthesis of Silver Nanoparticles and Exploring Their Potential of Reducing the Contamination of the In Vitro Culture Media and Inducing the Callus Growth ofMolecules (Basel, Switzerland) · 2023Article
- Therapeutic Applications of Biogenic Silver Nanomaterial Synthesized from the Paper Flower ofNanomaterials (Basel, Switzerland) · 2023Article
- Silver nanoparticle as an alternate to antibiotics in cattle semen during cryopreservation.Animal reproduction · 2023Article
- Towards further understanding the applications of endophytes: enriched source of bioactive compounds and bio factories for nanoparticles.Frontiers in plant science · 2023Review
- A Time-Course Study on a Food Contact Material (FCM)-Certified Coating Based on Titanium Oxide Deposited onto Aluminum.Biology · 2022Article
- Inhibition of the Vancomycin Resistance inBioMed research international · 2022Article
- In Vitro Antioxidant, Antitumor and Photocatalytic Activities of Silver Nanoparticles Synthesized UsingMolecules (Basel, Switzerland) · 2021Article
- Pharmacological properties of biogenically synthesized silver nanoparticles using endophyteSaudi journal of biological sciences · 2021Article
- Characterization and Genome Analysis ofPharmaceutics · 2021Article
- Recent trends in microbial nanoparticle synthesis and potential application in environmental technology: a comprehensive review.Environmental science and pollution research international · 2021Review
- Evaluation of Long-Lasting Antibacterial Properties and Cytotoxic Behavior of Functionalized Silver-Nanocellulose Composite.Materials (Basel, Switzerland) · 2021Article
- Endophytic BacteriaPharmaceutics · 2021Article
- Antimicrobial and In Vitro Cytotoxic Efficacy of Biogenic Silver Nanoparticles (Ag-NPs) Fabricated by Callus Extract ofBiomolecules · 2021Article
- Characterization, Antimicrobial and Antioxidant Evaluation of Biofabricated Silver Nanoparticles from EndophyticJournal of inorganic and organometallic polymers and materials · 2021Article
- EndophyticAntibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diseases caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.